Artificial Intelligence Remote Patient Monitoring Market: Market Size & Forecast 2026

AI-RPM combines continuous data collection from wearables, in-home sensors, and connected medical devices with algorithms that detect anomalies, predict deterioration, and triage alerts for clinicians. The market encompasses AI-enabled hardware, software platforms, and the services that integrate these tools into care pathways for chronic and post-acute patients. Current global revenue is around $2.5 billion in 2025 and is forecast to grow at roughly 26.5% annually through the end of the decade.

• •Market size in 2025: approximately USD 2.5 billion
• •Compound annual growth rate (CAGR): about 26.5%
• •Forecast value by 2030: roughly USD 8.4 billion

Rising rates of cardiovascular disease, diabetes, and respiratory conditions are creating sustained demand for continuous monitoring solutions that can reduce hospital readmissions. Reimbursement reforms in the United States, including expanded coverage for Remote Physiologic Monitoring (RPM) and Remote Therapeutic Monitoring (RTM) codes, are making AI-RPM economically viable for providers. At the same time, advances in edge AI chips, low-power connectivity, and cloud-native analytics are making devices smaller, smarter, and less expensive.

• •Growing burden of chronic disease and aging populations worldwide
• •Expansion of CPT reimbursement for remote monitoring services in the U.S.
• •Maturing sensor, edge-AI, and cloud analytics technologies

By component, the market splits into AI-enabled devices (wearables, biosensors, smart implants) and supporting software and services. By clinical application, cardiovascular monitoring currently represents the largest segment, followed by diabetes, respiratory, and sleep monitoring. North America leads adoption due to strong reimbursement and digital health infrastructure, while Asia-Pacific is the fastest-growing region as China, India, and Japan scale telehealth investments.

• •Cardiovascular monitoring is the leading clinical application segment
• •North America holds the largest revenue share; Asia-Pacific is growing fastest
• •Hardware accounts for the majority of component revenue today

What are the recent trends and outlook?

Generative AI is beginning to summarize longitudinal RPM data for clinicians, moving beyond simple threshold alerts toward predictive and prescriptive insights. Health systems and insurers are tying reimbursement to outcomes, favoring platforms that can demonstrably reduce admissions and total cost of care. Regulatory clarity from the FDA's evolving software-as-a-medical-device (SaMD) framework is expected to accelerate approvals of adaptive AI monitoring tools through 2030.

• •Generative AI copilots for clinicians analyzing continuous monitoring data
• •Value-based care models tying payment to measurable RPM outcomes
• •Clearer FDA SaMD guidance expected to speed AI monitoring approvals